课题基金 / 基金详情

项目摘要

项目成果

PAUL M LIEBERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
核心A--项目摘要 核心A是整个项目的管理中心。核心A将提供必要的行政支持 对于每个项目和核心中的所有调查人员。这包括财政管理和对所有人的监督 计划项目的组成部分;及时报告结果和里程碑报告、组织和 沟通所有计划项目会议和活动,包括内部和外部咨询会议; 方案研讨会和外联活动。核心A还为每个项目和核心提供生物统计支持, 组学数据的数据分析和假设检验、生物路径和网络分析。总目标 这一核心的目的是促进项目和核心之间的无缝互动,科学地和 技术成果,并协调程序之间复杂数据集的解释和通信 会员。核心A行政部分将确保遵守所有监管和政府 指导方针,财务管理,提供科学的领导,有效地沟通所有成员和 顾问,以及确保协调所有计划项目活动的行政支持结构。
英文摘要
CORE A – PROJECT SUMMARY Core A is the Administrative center of the entire Program. Core A will provide the essential administrative support for all of the investigators in each project and core. This includes fiscal management and oversight for all components of the Program Project; timely reporting of results and milestone reports, organization and communication of all Program Project meetings and activities, including internal and external advisory meetings, programmatic seminars, and outreach. Core A also provides Biostatistics support for each project and core, data analysis and hypothesis testing, biological pathways and network analysis of omics data. The overall goal of this Core is to facilitate the seamless interaction of projects and cores, communicate scientific and technological findings, and harmonize interpretation and communication of complex data sets between program members. The Core A administrative component will ensure compliance with all regulatory and governmental guidelines, fiscal management, provide scientific leadership, effective communication to all members and advisors, and an administrative support structure to ensure the coordination of all Program Project activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
  • 批准号:
    10714176
  • 项目类别:
  • 资助金额:
    $47.49万
  • 财政年份:
    2023
  • 负责人:
    PAUL M LIEBERMAN
  • 依托单位:
Epigenomic Drivers of EBV Epithelial Cancers
  • 批准号:
    10627690
  • 项目类别:
  • 资助金额:
    $46.97万
  • 财政年份:
    2023
  • 负责人:
    PAUL M LIEBERMAN
  • 依托单位:
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
  • 批准号:
    10627689
  • 项目类别:
  • 资助金额:
    $243.61万
  • 财政年份:
    2023
  • 负责人:
    PAUL M LIEBERMAN
  • 依托单位:
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
  • 批准号:
    10719866
  • 项目类别:
  • 资助金额:
    $74.58万
  • 财政年份:
    2023
  • 负责人:
    PAUL M LIEBERMAN
  • 依托单位:
海外基金